Your browser doesn't support javascript.
loading
Factors associated with non-carbapenemase mediated carbapenem resistance of Gram-negative bacteria: a retrospective case-control study
Müller, Marius; Wiencierz, Andrea; Gehringer, Christian; Muigg, Veronika; Bassetti, Stefano; Siegemund, Martin; Hinic, Vladimira; Tschudin Sutter, Sarah; Egli, Adrian.
Afiliación
  • Müller, Marius; University Hospital Basel. Clinical Bacteriology and Mycology. Basel. Switzerland
  • Wiencierz, Andrea; niversity Hospital Basel. Clinical Trial Unit. Basel. Switzerland
  • Gehringer, Christian; University Hospital Basel. Internal Medicine. University Hospital Basel. Basel. Switzerland
  • Muigg, Veronika; University Hospital Basel. Clinical Bacteriology and Mycology. Basel. Switzerland
  • Bassetti, Stefano; University Hospital Basel. Internal Medicine. Basel. Switzerland
  • Siegemund, Martin; University of Basel. Department of Clinical Research. University Hospital Basel. Basel. Switzerland
  • Hinic, Vladimira; University Hospital Basel. Clinical Bacteriology and Mycology. Basel. Switzerland
  • Tschudin Sutter, Sarah; University Hospital Basel. Infectious Diseases and Hospital Epidemiology. Basel. Switzerland
  • Egli, Adrian; University of Zurich. Institute of Medical Microbiology. University Hospital Basel. Zurich. Switzerland
Int. microbiol ; 27(2): 597-606, Abr. 2024. graf
Article en En | IBECS | ID: ibc-232304
Biblioteca responsable: ES1.1
Ubicación: ES15.1 - BNCS
ABSTRACT
Infections with carbapenemase-producing Gram-negative bacteria are related to increased morbidity and mortality, yet little is known regarding infections caused by non-beta-lactamase mediated carbapenem-resistant bacteria. Our objective was to identify risk factors for, and the clinical impact of infections caused by carbapenem-resistant carbapenemase-negative Enterobacterales and Pseudomonas aeruginosa. This retrospective matched case-control study was performed at the University Hospital of Basel, Switzerland, in 2016. We focused on other resistance mechanisms by excluding laboratory-confirmed carbapenemase-positive cases. Carbapenem resistance was set as the primary endpoint, and important risk factors were investigated by conditional logistic regression. The clinical impact of carbapenem resistance was estimated using regression models containing the resistance indicator as explanatory factor and adjusting for potential confounders. Seventy-five cases of infections with carbapenem-resistant, carbapenemase-negative bacteria were identified and matched with 75 controls with carbapenem-susceptible infections. The matched data set was well-balanced regarding age, gender, and comorbidity. Duration of prior carbapenem treatment (OR 1.15, [1.01, 1.31]) correlated with resistance to carbapenems. Our study showed that patients with carbapenem-resistant bacteria stayed 1.59 times (CI [0.81, 3.14]) longer in an ICU. The analyzed dataset did not provide evidence for strong clinical implications of resistance to carbapenems or increased mortality. The duration of prior carbapenem treatment seems to be a strong risk factor for the development of carbapenem resistance. The higher risk for a longer ICU stay could be a consequence of a carbapenem resistance. In contrast to carbapenemase-producers, the clinical impact of carbapenamase-negative, carbapenem-resistant strains may be limited... (AU)
Asunto(s)
Buscar en Google
Colección: 06-national / ES Banco de datos: IBECS Asunto principal: Beta-Lactamasas / Morbilidad / Mortalidad / Infecciones por Bacterias Gramnegativas Límite: Adult / Humans Idioma: En Revista: Int. microbiol Año: 2024 Tipo del documento: Article
Buscar en Google
Colección: 06-national / ES Banco de datos: IBECS Asunto principal: Beta-Lactamasas / Morbilidad / Mortalidad / Infecciones por Bacterias Gramnegativas Límite: Adult / Humans Idioma: En Revista: Int. microbiol Año: 2024 Tipo del documento: Article